[Presence and regulation of plasma with natriuretic and Na-K ATPase inhibitory properties in normotensive subjects].
In hypertension, mainly low renin subjects, a plasma Na-K ATPase inhibitor has yet been demonstrated. Moreover, it has been established that the concentration of this activity may be modulated by variations of the sodium and water balance. In the present study, such an activity and its role has been searched in the plasma of young healthy normotensive population. Its potential natriuretic property has also been tested. Twenty male subjects, younger than 30, volunteered 3 very different sodium diets: normal (+/- 170 mM/d), very low (-20 mM/d) and very high sodium intake (+340 mM/d). At the end of each period, some clinical and biological parameters have been studied: blood pressure, weight, vascular resistances and reactivity to norepinephrine, 24 h natriuresis, and plasma renin activity. Furthermore, the plasma natriuretic activity has been tested after filtration of the plasma across different Amicon filters to measure the effect of plasma extracts from 500 to 10,000 daltons (LMW) on fractional sodium excretion (FENa) after injection of such extracts in vivo in rat renal artery. For detection of a plasma Na-K ATPase inhibitor activity, 1/5 th diluted fresh plasma and LMW extracts have been incubated with purified rabbit renal Na-K ATPase enzyme and compared with the activity of this enzyme without such an incubation of plasma. We have observed that when the amount of sodium in the diet is higher, weight, systolic blood pressure, and vascular reactivity to norepinephrine increase. In the same condition, there are greater natriuretic activity in the LMW extracts and Na-K ATPase inhibitor activity in fresh plasma and LMW extracts of the normotensive people.(ABSTRACT TRUNCATED AT 250 WORDS)
Krzesinski
J M
JM
Service de Néphrologie, CHU Sart Tilman, Université de Liège, Belgique.
Potier
J P
JP
Godon
J P
JP
Rorive
G L
GL
D000328:Adult; D001794:Blood Pressure; D004912:Erythrocytes / Q000378:metabolism; D006801:Humans; D008297:Male; D008970:Molecular Weight; D045283:Natriuretic Agents / Q000032:analysis / Q000097:blood*; D012982:Sodium, Dietary / Q000008:administration & dosage; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors*
D045283:Natriuretic Agents; D012982:Sodium, Dietary; D000254:Sodium-Potassium-Exchanging ATPase
Présence et régulation d'une activité plasmatique à vertu natriurétique et inhibitrice de la Na-K ATPase chez des sujets normotendus.